1. Home
  2. FTNT vs MDT Comparison

FTNT vs MDT Comparison

Compare FTNT & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortinet Inc.

FTNT

Fortinet Inc.

HOLD

Current Price

$176.33

Market Cap

125.4B

Sector

Technology

ML Signal

HOLD

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$89.50

Market Cap

107.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTNT
MDT
Founded
2000
1949
Country
United States
Ireland
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.4B
107.0B
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
FTNT
MDT
Price
$176.33
$89.50
Analyst Decision
Hold
Buy
Analyst Count
25
21
Target Price
$85.71
★ $108.21
AVG Volume (30 Days)
3.6M
★ 8.8M
Earning Date
05-06-2026
06-03-2026
Dividend Yield
N/A
★ 3.58%
EPS Growth
★ 7.08
3.32
EPS
★ 1.54
1.14
Revenue
$6,799,600,000.00
★ $36,364,000,000.00
Revenue This Year
$14.02
$8.91
Revenue Next Year
$10.51
$6.54
P/E Ratio
$112.66
★ $77.63
Revenue Growth
★ 14.17
8.43
52 Week Low
$73.55
$73.31
52 Week High
$181.37
$106.33

Technical Indicators

Market Signals
Indicator
FTNT
MDT
Relative Strength Index (RSI) 59.98 39.16
Support Level $148.09 $85.35
Resistance Level N/A $89.00
Average True Range (ATR) 6.46 1.75
MACD 0.90 -0.72
Stochastic Oscillator 81.48 14.78

Price Performance

Historical Comparison
FTNT
MDT

About FTNT Fortinet Inc.

Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Share on Social Networks: